All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
People

Bluegrass Bernedoodles: Professional Dog Breeders Announce Their Newest Bernedoodle Puppies for...

admin
Pr Newswire

/C O R R E C T I O N —...

admin
Pr Newswire

New Briefing from the Energy Transitions Commission (ETC) Addresses Global Trade...

admin
Pr Newswire

JINRO Unveils Global Collaboration with Netflix’s Season 3

admin
Pr Newswire

Rockefeller Foundation Announces First Class of Big Bets Fellows Focused on...

admin
Pr Newswire

WEKA and Nebius Partner to Catalyze AI Innovation With Ultra-High-Performance Cloud...

admin
People

Oddity Finance LLC Announces Upsize and Pricing of $525 Million Offering...

admin
People

Oklahoma Native Cody Burke Writes Picture Book That Serves as a...

admin
People

Turkey Prepaid Card and Digital Wallet Market Databook 2025: Turkey’s Market...

admin
People

Germany Social Commerce Market Databook 2025: Stricter Regulations Shape Germany’s Social...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...